You are here

Home

P2D, INC

Company Information
Address
2180 E Galbraith Rd Rm 124
Cincinnati, OH 45237-1625
United States


http://www.p2dinc.com/
Information

UEI: KX3EAX2JEMV8

# of Employees: 2
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 54

  1. BIOMARKER FOR SUBARACHNOID HEMORRHAGE

    Amount: $128,125.00

    DESCRIPTION (provided by applicant): The objective of this Phase I application is to develop a new quantitative clinical biomarker for subarachnoid hemorrhage (SAH). Acute headache is initially screen ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health

  2. BIOMARKER OF NEUROTOXICITY IN MENINGITIS

    Amount: $112,627.00

    DESCRIPTION (provided by applicant): The objective of this Phase I application is to develop a sensitive biomarker for quantifying neurotoxicity and neuroprotectant efficacy in meningitis. Previous re ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health

  3. MELATONIN ANALOG FOR SLEEP DISORDERS

    Amount: $100,000.00

    DESCRIPTION (PROVIDED BY APPLICANT): Phase 2 Discovery is developing a synthetic melatonin analog (PD6735) for the treatment of sleep disorders. PD6735 is being developed as a safe and effective trea ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health

  4. SSRI for Treating Depressed HIV Patients

    Amount: $107,366.00

    DESCRIPTION: (Verbatim from the Applicant's Abstract) The goal of this Phase I SBIR application is to develop a long acting injectable antidepressant for use in depressed, non-compliant HI ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government